These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 3772803

  • 1. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
    Dwoskin LP, Zahniser NR.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803
    [Abstract] [Full Text] [Related]

  • 2. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
    Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
    [Abstract] [Full Text] [Related]

  • 3. Biphasic modulation of evoked [3H]D-aspartate release by D-2 dopamine receptors in rat striatal slices.
    Peris J, Dwoskin LP, Zahniser NR.
    Synapse; 1988 Jun; 2(4):450-6. PubMed ID: 2973144
    [Abstract] [Full Text] [Related]

  • 4. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
    Snyder GL, Keller RW, Zigmond MJ.
    J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
    [Abstract] [Full Text] [Related]

  • 5. Frequency-dependent muscarinic receptor modulation of acetylcholine and dopamine release from rabbit striatum.
    James MK, Cubeddu LX.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):98-104. PubMed ID: 6707949
    [Abstract] [Full Text] [Related]

  • 6. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
    Teng L, Crooks PA, Sonsalla PK, Dwoskin LP.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
    [Abstract] [Full Text] [Related]

  • 7. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [Abstract] [Full Text] [Related]

  • 8. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS, Talmaciu RK, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [Abstract] [Full Text] [Related]

  • 9. Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.
    Agneter E, Hoffmann IS, Singer EA, Cubeddu LX.
    J Pharmacol Exp Ther; 1994 May; 269(2):470-6. PubMed ID: 8182513
    [Abstract] [Full Text] [Related]

  • 10. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
    [Abstract] [Full Text] [Related]

  • 11. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK, Sumithran SP, Dwoskin LP.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [Abstract] [Full Text] [Related]

  • 12. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.
    Dwoskin LP, Teng L, Buxton ST, Crooks PA.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):905-11. PubMed ID: 10027825
    [Abstract] [Full Text] [Related]

  • 13. Evidence for autoreceptor modulation of endogenous dopamine release from rabbit caudate nucleus in vitro.
    Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):492-500. PubMed ID: 3155797
    [Abstract] [Full Text] [Related]

  • 14. Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine.
    Teng L, Crooks PA, Buxton ST, Dwoskin LP.
    J Pharmacol Exp Ther; 1997 Nov; 283(2):778-87. PubMed ID: 9353398
    [Abstract] [Full Text] [Related]

  • 15. Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release.
    Maura G, Carbone R, Raiteri M.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1142-6. PubMed ID: 2574740
    [Abstract] [Full Text] [Related]

  • 16. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ, Arbilla S, Galzin AM, Langer SZ.
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [Abstract] [Full Text] [Related]

  • 17. Dopamine transporter mediated release of dopamine: role of chloride.
    Sitges M, Reyes A, Chiu LM.
    J Neurosci Res; 1994 Sep 01; 39(1):11-22. PubMed ID: 7807588
    [Abstract] [Full Text] [Related]

  • 18. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P, Arbilla S, Cantrill RC, Scatton B, Langer SZ.
    J Pharmacol Exp Ther; 1985 Oct 01; 235(1):220-9. PubMed ID: 3930699
    [Abstract] [Full Text] [Related]

  • 19. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D, Abercrombie ED, Zigmond MJ.
    J Pharmacol Exp Ther; 1993 Nov 01; 267(2):912-8. PubMed ID: 8246167
    [Abstract] [Full Text] [Related]

  • 20. Modulation of [3H]dopamine release from rabbit retina.
    Dubocovich ML.
    Fed Proc; 1984 Sep 01; 43(12):2714-8. PubMed ID: 6468669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.